Eliot H Ohlstein

Title: Eliot H Ohlstein: Innovator in Dopamine Research

Introduction

Eliot H Ohlstein is a notable inventor based in Plymouth Valley, Pennsylvania. He has made significant contributions to the field of pharmacology, particularly in the development of dopamine-.beta.-hydroxylase inhibitors. With a total of three patents to his name, Ohlstein's work has the potential to impact therapeutic approaches for various conditions.

Latest Patents

Ohlstein's latest patents focus on potent dopamine-.beta.-hydroxylase inhibitors. These inhibitors are designed to inhibit dopamine-.beta.-hydroxylase activity, which is crucial for regulating dopamine levels in mammals. The patents also include pharmaceutical compositions that incorporate these inhibitors, along with methods for their application in medical treatments. His innovative approach provides novel intermediates that are useful in preparing these inhibitors, showcasing his expertise in the field.

Career Highlights

Eliot H Ohlstein is associated with SmithKline Beecham Corporation, where he has contributed to groundbreaking research and development. His work has been instrumental in advancing the understanding of dopamine-related processes and their implications for health.

Collaborations

Ohlstein has collaborated with notable colleagues, including Lawrence I Kruse and Stephen T Ross. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.

Conclusion

Eliot H Ohlstein's contributions to the field of pharmacology through his patents on dopamine-.beta.-hydroxylase inhibitors highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.